Randomized trial · people
TB-500 on venous ulcers: safety comparable to placebo in Phase 2
Checked against the paper Randomized trialPublished by PepVault
The takeaway
An early human trial found thymosin beta 4 on venous ulcers had safety comparable to placebo, with early signs that the 0.03% dose might speed healing.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 73
- Published
- 2010
- Journal
- Ann N Y Acad Sci
What they tested
The team tested whether thymosin beta 4 put on the skin is safe, well tolerated and helpful for healing venous ulcers, which are long-lasting sores of the lower legs.
How the study was done
A double-blind, placebo-controlled, dose-escalation Phase 2 trial randomized 73 patients with venous stasis ulcers at European sites in Italy and Poland. Double-blind means neither patients nor staff knew who got the peptide, and placebo is a dummy treatment.

What they found
At every dose tested, the safety of thymosin beta 4 was judged acceptable and similar to placebo. The results pointed to the 0.03% dose as possibly speeding wound healing. About 25% of patients had their wounds close fully within 3 months, mainly when the wounds were of small or medium size, or of mild or moderate severity.
What it doesn’t show
This was a small, early-stage trial, and its signs of faster healing were preliminary, not a firm result. It tested the peptide applied to the skin of venous ulcers only, so it says nothing about other uses or other ways of giving it.
The paper
Guarnera et al. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci. 2010.
The compound
More studies on TB-500
- Thymosin beta-4: no overall infarct area cut in 96 STEMI patientsRandomized trial · people · 2025
- BPC-157: non-significant tendon gains in rats; TB-500 did betterAnimal study · rats · 2026
- Thymosin beta-4 in pregnant mice: longer newborns, more mature organsAnimal study · mice · 2021
- Thymosin beta-4 raised survival in mice with a coronavirus infectionAnimal study · mice · 2021
- Thymosin beta-4: more liver fibrosis in mice bred to make extra TB4Animal study · mice · 2017
- Thymosin beta-4 sped skin wound healing in diabetic and aged miceAnimal study · mice · 2003
- Every study on TB-500
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.